Evidence map›Paper›PMID 35839034›Full record

ArticleMedicine2022

Clinical features and mortality of COVID-19 patients admitted to ICU according to SOFA score.

Francisco Javier Gómez-Romero, José Ramón Muñoz-Rodríguez, Leticia Serrano-Oviedo, Inmaculada García-Jabalera, Pilar López-Juárez, José Manuel Pérez-Ortiz, Francisco Javier Redondo-Calvo, COVID-19 SESCAM Network

Abstract readMulticenter Study
In one paragraph

Article in Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francisco Javier Gómez-RomeroTranslational Research Unit, University General Hospital of Ciudad Real, Servicio de Salud de Castilla-La Mancha, Spain.
José Ramón Muñoz-RodríguezTranslational Research Unit, University General Hospital of Ciudad Real, Servicio de Salud de Castilla-La Mancha, Spain.
Leticia Serrano-OviedoTranslational Research Unit, University General Hospital of Ciudad Real, Servicio de Salud de Castilla-La Mancha, Spain.
Inmaculada García-JabaleraTranslational Research Unit, University General Hospital of Ciudad Real, Servicio de Salud de Castilla-La Mancha, Spain.
Pilar López-JuárezTranslational Research Unit, University General Hospital of Ciudad Real, Servicio de Salud de Castilla-La Mancha, Spain.
José Manuel Pérez-OrtizTranslational Research Unit, University General Hospital of Ciudad Real, Servicio de Salud de Castilla-La Mancha, Spain.ORCID 0000-0002-3588-6273
Francisco Javier Redondo-CalvoTranslational Research Unit, University General Hospital of Ciudad Real, Servicio de Salud de Castilla-La Mancha, Spain.
COVID-19 SESCAM Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Sequential Organ Failure Assessment (SOFA) could function as an effective risk stratification tool in the admission of critically ill patients with COVID-19 and would allow stratification based on a risk assessment. We aimed to examine whether the SOFA score is useful to define 2 severity profiles in COVID-19 patients admitted to ICU: mild with SOFA < 5, and severe with SOFA ≥ 5. A retrospective cohort, multicenter study was conducted from February 11 to May 11, 2020. We analyzed patients admitted to all ICUs of the 14 public hospitals of the Castilla-La Mancha Health Service at the beginning of the pandemic and with SARS-CoV-2 infection. Patients were divided in 2 groups according to the level of severity by SOFA at admission to the ICU. Cox regression was used to evaluate factors associated with survival and Kaplan-Meier test to examine survival probability. In total, 405 patients with a complete SOFA panel were recruited in the 14 participating ICUs. SOFA <5 group showed that age above 60 years and D-dimer above 1000 ng/mL were risk factors associated with lower survival. In SOFA ≥ 5 it was found that high blood pressure was a risk factor associated with shorter survival. Kaplan-Meier showed lower survival in SOFA ≥ 5 in combination with high blood pressure, time since viral symptom onset to admission in ICU < 7 days, D-dimer ≥1000 ng/mL and respiratory pathology. However, SOFA < 5 showed only higher age (≥60 years) associated with lower survival. Age over 60 years and D-dimer over 1000 ng/mL were risk factors reflecting lower survival in patients with SOFA < 5. Moreover, SOFA ≥ 5 patients within a week after COVID-19 onset and comorbidities such as high blood pressure and previous respiratory pathology showed lower survival.

Indexed as

COVID-19HypertensionHumansIntensive Care UnitsMiddle AgedOrgan Dysfunction ScoresPrognosisRetrospective StudiesSARS-CoV-2

Identifiers

PMID35839034
PMCPMC11132351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.